Your Messages Inbox
Your Article Summary
See Latest ArticlesBiosign appoints VP of business development
Canadian Healthcare Technology, 08/11/09
Biosign Technologies Inc. is pleased to announce the appointment of John T. Anders as Vice President Business Development and Sales. Mr. Anders is a respected healthcare executive with over 30 years experience in sales, marketing and financial planning leadership. He will be responsible for commercializing the proprietary capabilities of the company’s UFIT device and the many healthcare software applications that it drives.
Related Articles
Insight Health Apppints James Shriver VP of Sales Marketing
Imaging Economics, 10/15/09
Relevance Score: 67%
Are You Ready For The Revolution
PharmExec, 10/16/09
Relevance Score: 66%
Mylans Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier
Mylan, 11/16/09
Relevance Score: 65%
Facilitating collaborative development in practice
International Journal of Nursing Practice, 10/13/09
Relevance Score: 65%
Pro Bono Humanum Award-Jeffrey Sachs,Director of The Earth Institute
PharmExec, 10/13/09
Relevance Score: 65%
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
Bristol Myers-Squibb Company, 12/15/09
AHIMA Selects its Leader
HealthDataManagement, 12/14/09
Dendreon Appoints Hans Bishop as Chief Operating Officer
Dendreon Coproration, 12/11/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
Watson Pharmaceuticals, 12/15/09
MediGene AG Decides on a Revision of the Development Plans for EndoTAG(TM)-1 and RhuDex(TM), and Downsizes its Executive Board
MediGene, 12/15/09
Phase III Study Demonstrates INVEGA SUSTENNA Statistically Similar to RISPERDAL CONSTA Long-Acting Injection
Janssen, 12/15/09
Article Search
Sponsor